Next steps and barriers to implementing lung cancer screening with low-dose CT

British Journal of Radiology

Volumn 87, Issue 1044, 2014, Pages

  Baldwin, D R ^a   O'Dowd, E L ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL PATHWAY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; HEALTH PROGRAM; HUMAN; LUNG CANCER; META ANALYSIS (TOPIC); NOTE; PATIENT HARM; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SCREENING TEST; THORAX RADIOGRAPHY; ATTITUDE TO HEALTH; EARLY DIAGNOSIS; LUNG TUMOR; MASS SCREENING; PROCEDURES; RADIOGRAPHY; TRENDS;

ATTITUDE TO HEALTH; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; RADIATION DOSAGE;

EID: 84911909774     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140416     Document Type: Note

References (31)

1. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409. doi: 10.1056/NEJMoa1102873
2. Available from: http://www.cancer.gov/cancertopics/pdq/screening/overview/HealthProfessional#Section-10
3. UK National Screening Committee. Programme appraisal criteria. Available from: http://www.screening.nhs.uk/criteria
4. Cancer Research UK. Cancer mortality in the UK in 2012. Available from: http://publications. cancerresearchuk.org/downloads/Product/CS-REPORT-MORTALITY.pdf
5. America Cancer Society. Cancer facts and figures 2014. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
6. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323-9.
7. Riaz SP, Linklater KM, Page R, Peake MD, Møller H, Lüchtenborg M. Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax 2012; 67: 811-14. doi: 10.1136/thoraxjnl-2012-201768
8. Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007; 110: 2370-84.
9. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 347-60.
10. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345-57. doi: 10.1056/NEJMoa1114635
11. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013; 159: 411-20. doi: 10.7326/0003-4819-159-6-201309170-00690
12. Field JK, Hansell DM, Duffy SW, Baldwin DR. CT screening for lung cancer: countdown to implementation. Lancet Oncol 2013; 14: e591-600. doi: 10.1016/S1470-2045(13)70293-6
13. Pinsky PF, Gierada DS, Hocking W, Patz EF Jr, Kramer BS. National Lung Screening Trial findings by age: medicare-eligible versus under-65 population. Ann Intern Med Sep 2014. doi: 10.7326/M14-1484
14. Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, et al. The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. J Thorac Oncol 2014; 9: 141-3. doi: 10.1097/JTO.0000000000000060
15. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012; 7: 10-19. doi: 10.1097/JTO.0b013e31823c58ab
16. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-9. doi: 10.1056/NEJMoa0906085
17. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368: 728-36. doi: 10.1056/NEJMoa1211776
18. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CTscreening according to the risk of lung-cancer death. N Engl J Med 2013; 369: 245-54. doi: 10.1056/NEJMoa1301851
19. McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, et al. The UK Lung Screen (UKLS): demographic profile of first 88, 897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014; 7: 362-71. doi: 10.1158/1940-6207
20. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011; 66: 308-13. doi: 10.1136/thx.2010.152066
21. Independent UKPoBCS. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86. doi: 10.1016/S0140-6736(12) 61611-0
22. Duffy SW, Field JK, Allgood PC, Seigneurin A. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer 2014; 110: 1834-40. doi: 10.1038/bjc.2014.63
23. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, et al. Over-diagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014; 174: 269-74. doi: 10.1001/jamainternmed.2013.12738
24. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19 (Suppl. 1): 42-56.
25. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011; 38: 154-61. doi: 10.1183/09031936.00123410
26. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010; 65: 600-5. doi: 10.1136/thx.2009.133751
27. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) 2012; 31: 770-9. doi: 10.1377/hlthaff.2011.0814
28. Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One 2013; 8: e71379. doi: 10.1371/journal. pone.0071379
29. Shmueli A, Fraifeld S, Peretz T, Gutfeld O, Gips M, Sosna J, et al. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience. Value Health 2013; 16: 922-31. doi: 10.1016/j.jval.2013.05.007
30. Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, et al. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax 2011; 66: 736-7. doi: 10.1136/thoraxjnl-2011-200351
31. Department of Heath. Justification of computed tomography (CT) for individual health assessment. Expert Working Party Report. Available from: https://www. gov.uk/government/uploads/system/uploads/attachment-data/file/326572/IHA-June-Report.pdf